BioNexus Gene Lab Operating Expenses 2019-2024 | BGLC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioNexus Gene Lab operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

BioNexus Gene Lab Operating Expenses 2019-2024 | BGLC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioNexus Gene Lab operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$120.6B
Cencora (COR)	$44.1B
ICON (ICLR)	$23.6B
DiDi Global (DIDIY)	$22.4B
Avantor (AVTR)	$17.7B
Revvity (RVTY)	$15.6B
Natera (NTRA)	$15.3B
Viatris (VTRS)	$13.9B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$11.8B
Charles River Laboratories (CRL)	$10.2B
Medpace Holdings (MEDP)	$10.1B
Sonic Healthcare (SKHHY)	$9.1B
Doximity (DOCS)	$7.9B
HealthEquity (HQY)	$6.9B
Bausch + Lomb (BLCO)	$6.7B
PACS (PACS)	$6B
Organon (OGN)	$4.9B
Life Times (LTH)	$4.9B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.1B
Concentras Parent (CON)	$2.9B
Ardent Health Partners (ARDT)	$2.7B
GoodRx Holdings (GDRX)	$2.5B
BrightSpring Health Services (BTSG)	$2.5B
Alignment Healthcare (ALHC)	$2.1B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$2B
AMN Healthcare Services Inc (AMN)	$1.6B
CareDx (CDNA)	$1.6B